Biotest AG Logo

Biotest AG

ISIN: DE0005227235 | Ticker: BIO3 | LEI: 529900JVX7RPXBLYUD89
Sector: Health Care – Sub-Industry: Biotechnology
Country: Germany

About Biotest AG

Company Description

Biotest is a global company that supplies plasma protein products and biotherapeutic drugs. Our products are primarily used in the therapeutic areas of clinical immunology, haematology and intensive care medicine. For patients with serious and often chronic diseases they provide targeted treatment, which generally enable them to lead almost normal lives.
Within our areas of specialisation, we start from pre-clinical and clinical development to manufacturing and global marketing. Research, development and production are carried out at our main headquarters in Germany. Our own sales organisations (subsidiaries) and cooperating partners represent our global distribution network.

Year founded

1946

Served area

Worldwide

Headcount

1,663

Headquarters

Landsteinerstraße 5, 63303 Dreieich – Germany

Filings & Publications

Insider Trades

Date Trading entity / Person Association Trade type Volume
29.11.21 BernΓΆster, Dr. Katrin Other Sell EUR 15,640.00
29.11.21 Realsoul Holding S.A. Close relation Buy EUR 1,713.60
18.11.21 Fleck, Stephan Other Sell EUR 120,870.00
18.11.21 SchΓΌttrumpf, Dr. JΓΆrg Other Sell EUR 99,895.50
18.11.21 Reinecke, Dr. Martin Other Sell EUR 37,715.00
18.11.21 Moritz, Michael Other Sell EUR 35,460.00

Capital markets information

ISIN

DE0005227235

LEI

529900JVX7RPXBLYUD89

Sector

Health Care

Industry Group

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Biotechnology

Sub-Industry

Biotechnology

Listed Stock Exchange

Frankfurt Stock Exchange

Contact Investor Relations department

Stay up to date

Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.